Kiromic BioPharma, Inc. (NASDAQ:KRBP – Get Free Report) was up 1.5% during mid-day trading on Tuesday . The stock traded as high as $2.64 and last traded at $2.64. Approximately 355 shares were traded during mid-day trading, a decline of 96% from the average daily volume of 8,360 shares. The stock had previously closed at $2.60.
Kiromic BioPharma Price Performance
The company has a market cap of $3.50 million, a price-to-earnings ratio of -0.18 and a beta of 2.00. The firm’s 50 day simple moving average is $2.67 and its 200-day simple moving average is $1.44.
Kiromic BioPharma (NASDAQ:KRBP – Get Free Report) last released its quarterly earnings data on Monday, March 18th. The company reported ($4.16) earnings per share (EPS) for the quarter.
About Kiromic BioPharma
Kiromic BioPharma, Inc, an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell (GDT) to target solid tumors. The company develops ALEXIS-ISO-1, an allogeneic GDT therapy product that targets an isoform of mesothelin; and ALEXIS-PRO-1, an allogeneic GDT therapy product that targets PD-L1.
Recommended Stories
- Five stocks we like better than Kiromic BioPharma
- What to Know About Investing in Penny Stocks
- Hasbro’s Management Made All the Right Calls This Quarter
- Where Do I Find 52-Week Highs and Lows?
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- 5 discounted opportunities for dividend growth investors
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Kiromic BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kiromic BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
